DK1265914T3 - WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme - Google Patents

WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme

Info

Publication number
DK1265914T3
DK1265914T3 DK01920759T DK01920759T DK1265914T3 DK 1265914 T3 DK1265914 T3 DK 1265914T3 DK 01920759 T DK01920759 T DK 01920759T DK 01920759 T DK01920759 T DK 01920759T DK 1265914 T3 DK1265914 T3 DK 1265914T3
Authority
DK
Denmark
Prior art keywords
wnt
same
nucleic acids
acids encoding
related polypeptides
Prior art date
Application number
DK01920759T
Other languages
Danish (da)
English (en)
Inventor
Luca K Rastelli
Diane Pennica
Original Assignee
Curagen Corp
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Genentech Inc filed Critical Curagen Corp
Application granted granted Critical
Publication of DK1265914T3 publication Critical patent/DK1265914T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01920759T 2000-03-22 2001-03-22 WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme DK1265914T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19125800P 2000-03-22 2000-03-22
PCT/US2001/009600 WO2001070775A2 (en) 2000-03-22 2001-03-22 Wnt-1 related polypeptides, and nucleic acids encoding the same

Publications (1)

Publication Number Publication Date
DK1265914T3 true DK1265914T3 (da) 2008-03-10

Family

ID=38885296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01920759T DK1265914T3 (da) 2000-03-22 2001-03-22 WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme

Country Status (11)

Country Link
US (3) US20020098540A1 (pt)
EP (1) EP1265914B1 (pt)
JP (1) JP2003527849A (pt)
AT (1) ATE382055T1 (pt)
AU (2) AU2001247781C1 (pt)
CA (1) CA2404216A1 (pt)
DE (1) DE60132075T2 (pt)
DK (1) DK1265914T3 (pt)
ES (1) ES2298226T3 (pt)
PT (1) PT1265914E (pt)
WO (1) WO2001070775A2 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114644D0 (en) * 2001-06-15 2001-08-08 Oxford Glycosciences Uk Ltd Protein
WO2003087163A1 (fr) 2002-04-15 2003-10-23 Chugai Seiyaku Kabushiki Kaisha Procede d'elaboration d'une banque scdb
WO2004065611A1 (ja) 2003-01-21 2004-08-05 Chugai Seiyaku Kabushiki Kaisha 抗体の軽鎖スクリーニング方法
JP4794301B2 (ja) 2003-06-11 2011-10-19 中外製薬株式会社 抗体の製造方法
WO2005042582A1 (ja) * 2003-11-04 2005-05-12 Chugai Seiyaku Kabushiki Kaisha 抗体の製造方法
US20050251054A1 (en) * 2004-05-10 2005-11-10 Medpond, Llc Method and apparatus for measurement of autonomic nervous system function
US9493569B2 (en) 2005-03-31 2016-11-15 Chugai Seiyaku Kabushiki Kaisha Structural isomers of sc(Fv)2
JP5620626B2 (ja) 2005-03-31 2014-11-05 中外製薬株式会社 会合制御によるポリペプチド製造方法
AU2006256041B2 (en) 2005-06-10 2012-03-29 Chugai Seiyaku Kabushiki Kaisha Stabilizer for protein preparation comprising meglumine and use thereof
KR101360671B1 (ko) 2005-06-10 2014-02-07 추가이 세이야쿠 가부시키가이샤 ｓｃ（Ｆｖ）２를 함유하는 의약조성물
US9670269B2 (en) 2006-03-31 2017-06-06 Chugai Seiyaku Kabushiki Kaisha Methods of modifying antibodies for purification of bispecific antibodies
CN103695530B (zh) 2008-07-07 2016-05-25 牛津纳米孔技术有限公司 酶-孔构建体
JP2011527191A (ja) 2008-07-07 2011-10-27 オックスフォード ナノポア テクノロジーズ リミテッド 塩基検出細孔
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
JP2012516145A (ja) * 2009-01-30 2012-07-19 オックスフォード ナノポア テクノロジーズ リミテッド ハイブリダイゼーションリンカー
AU2010209528B2 (en) 2009-01-30 2015-10-01 Oxford Nanopore Technologies Limited Adaptors for nucleic acid constructs in transmembrane sequencing
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
US9751915B2 (en) 2011-02-11 2017-09-05 Oxford Nanopore Technologies Ltd. Mutant pores
AU2012288629B2 (en) 2011-07-25 2017-02-02 Oxford Nanopore Technologies Limited Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
WO2013153359A1 (en) 2012-04-10 2013-10-17 Oxford Nanopore Technologies Limited Mutant lysenin pores
EP2875154B1 (en) 2012-07-19 2017-08-23 Oxford Nanopore Technologies Limited SSB method for characterising a nucleic acid
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
JP6408494B2 (ja) 2013-03-08 2018-10-17 オックスフォード ナノポール テクノロジーズ リミテッド 酵素停止法
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
RU2758952C1 (ru) 2013-09-27 2021-11-03 Чугаи Сейяку Кабусики Кайся Способ получения полипептидного гетеромультимера
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
WO2015166276A1 (en) 2014-05-02 2015-11-05 Oxford Nanopore Technologies Limited Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
WO2016034591A2 (en) 2014-09-01 2016-03-10 Vib Vzw Mutant pores
WO2016055778A1 (en) 2014-10-07 2016-04-14 Oxford Nanopore Technologies Limited Mutant pores
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
KR20180091918A (ko) 2015-12-28 2018-08-16 추가이 세이야쿠 가부시키가이샤 Fc 영역 함유 폴리펩타이드의 정제를 효율화하기 위한 방법
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method
CN114457052B (zh) * 2021-09-17 2024-02-27 厦门大学 一种抗肿瘤的多肽组合物及其应用

Also Published As

Publication number Publication date
JP2003527849A (ja) 2003-09-24
AU2001247781B2 (en) 2006-02-02
US20020098540A1 (en) 2002-07-25
AU2001247781C1 (en) 2006-08-17
EP1265914A2 (en) 2002-12-18
ATE382055T1 (de) 2008-01-15
DE60132075T2 (de) 2009-03-12
US20080206252A1 (en) 2008-08-28
PT1265914E (pt) 2008-04-08
DE60132075D1 (de) 2008-02-07
WO2001070775A3 (en) 2002-01-10
WO2001070775A2 (en) 2001-09-27
ES2298226T3 (es) 2008-05-16
US20050159373A1 (en) 2005-07-21
CA2404216A1 (en) 2001-09-27
AU4778101A (en) 2001-10-03
EP1265914B1 (en) 2007-12-26

Similar Documents

Publication Publication Date Title
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69838143D1 (de) Antimikrobielle peptide
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE329028T1 (de) Nl3 tie rezeptortyrosinekinase ligandhomologe
ES8407097A1 (es) Un procedimiento para obtener una proteina hibrida.
WO2002016418A3 (en) An iap binding peptide or polypeptide and methods of using the same
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
CY1110381T1 (el) Πεπτιδια χ-κωνοτοξινης ως αναστολεις των νευρωνικων αμινικων μεταφορεων
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
EP1132402A4 (en) PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTIVE ACTIVITY
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
GB9416536D0 (en) Orphan receptor
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
WO2001070808A3 (en) Angiogenesis - associated proteins, and nucleic acids encoding the same
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
WO2001098355A3 (en) Cgi-69 compositions and methods of use
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE69831584D1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
CO5400145A1 (es) Proteina asociada con enfermedad
WO2002097036A3 (en) Compositions and methods for adipose abundant protein
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same